Changes in serum fibronectin levels predict tumor recurrence in patients with early hepatocellular carcinoma after curative treatment
Sign Up to like & getrecommendations! Published in 2020 at "Scientific Reports"
DOI: 10.1038/s41598-020-78440-w
Abstract: Fibronectin, a matrix glycoprotein aberrantly expressed in various tumor cells, is a known candidate biomarker for the early diagnosis of hepatocellular carcinoma (HCC). In this study, we investigated whether serum fibronectin levels could predict tumor… read more here.
Keywords: fibronectin levels; recurrence; curative treatment; treatment ... See more keywords